Defective homologous recombination repair and carcinogenesis

有缺陷的同源重组修复和致癌作用

基本信息

  • 批准号:
    12213088
  • 负责人:
  • 金额:
    $ 32.45万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
  • 财政年份:
    2000
  • 资助国家:
    日本
  • 起止时间:
    2000 至 2004
  • 项目状态:
    已结题

项目摘要

A defect in homologous recombination repair has been implicated in carcinogenesis because hereditary breast cancer genes BRCA were shown to play an important role in homologous recombination repair. We have investigated a molecular mechanism of homologous recombination repair in human cells. Rad54B, a gene identified as a novel recombination repair gene, exhibits the double-strand DNA-dependent ATPase activity and is required for gene targeting in human cells. XRCC3, a member of Rad51 paralog, is required for homologous recombination via sister chromatids. Additionally, XRCC3 prevents DNA rereplication and endoreduplication, thereby ensuring chromosome integrity. The T241M variant, a genetic polymorphism implicated in cancer risk, exhibits intact recombination repair, but fails to prevent endoreduplication, suggesting that an increase in endoreduplication is associated with cancer risk. A similar phenotype is observed in a resolvase gene Mus81-deficient cells. This aberration is caused by Cyclin B/Cdc2 inhibition by Chk2 activation in response to DNA damage. Thus, the recombination machinery is tightly associated with DNA replication and cell-cycle regulation. This finding suggests that a defect in the DNA metabolic network induces chromosome instability.
由于遗传性乳腺癌基因BRCA在同源重组修复中起重要作用,因此同源重组修复缺陷与癌发生有关。我们研究了人类细胞中同源重组修复的分子机制。Rad 54 B是一个新的重组修复基因,具有双链DNA依赖的ATP酶活性,是人类细胞基因打靶所必需的。XRCC 3是Rad 51同源染色体的一个成员,是通过姐妹染色单体进行同源重组所必需的。此外,XRCC 3阻止DNA再复制和核内再复制,从而确保染色体的完整性。T241 M变体是一种与癌症风险有关的遗传多态性,表现出完整的重组修复,但未能阻止核内复制,这表明核内复制的增加与癌症风险有关。在解离酶基因Mus 81缺陷细胞中观察到类似的表型。这种畸变是由响应于DNA损伤的Chk 2活化的Cyclin B/Cdc 2抑制引起的。因此,重组机制与DNA复制和细胞周期调控密切相关。这一发现表明,DNA代谢网络的缺陷会导致染色体不稳定。

项目成果

期刊论文数量(68)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Takahashi, T.: "Evident for RAD51L1/HMGIC fusion in the pathogenesis of uterine leiomyoma"Genes Chromosomes Cancer. 30(2). 196-201 (2001)
Takahashi, T.:“RAD51L1/HMGIC 融合​​在子宫肌瘤发病机制中的证据”基因染色体癌症。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Tanaka,K.: "A novel human Rad54 homologue, Rad54B, associates with Rad51"J.Biol.Chem.. 275(34). 26316-26321 (2000)
Tanaka,K.:“一种新的人类 Rad54 同源物 Rad54B,与 Rad51 相关”J.Biol.Chem.. 275(34)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Human Rad54B is a double-stranded DNA-dependent ATPase and has biochemical properties different from its structural homolog in yeast, Tid1/Rdh54
人类 Rad54B 是一种双链 DNA 依赖性 ATP 酶,其生化特性不同于其在酵母中的结构同源物 Tid1/Rdh54
  • DOI:
  • 发表时间:
    2002
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Tanaka;K.
  • 通讯作者:
    K.
A role for RAD54B in homologous recombination in human cells
  • DOI:
    10.1093/emboj/21.1.175
  • 发表时间:
    2002-01-15
  • 期刊:
  • 影响因子:
    11.4
  • 作者:
    Miyagawa, K;Tsuruga, T;Tanaka, K
  • 通讯作者:
    Tanaka, K
Deoxycytidyl transferase activity of the human REV1 protein is closely associated with the conserved polymerase domain
  • DOI:
    10.1074/jbc.m008082200
  • 发表时间:
    2001-05-04
  • 期刊:
  • 影响因子:
    4.8
  • 作者:
    Masuda, Y;Takahashi, M;Kamiya, K
  • 通讯作者:
    Kamiya, K
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MIYAGAWA Kiyoshi其他文献

MIYAGAWA Kiyoshi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MIYAGAWA Kiyoshi', 18)}}的其他基金

Regulation of radiation sensitivity by a pathway linking DNA repair with cell-cycle control
通过连接 DNA 修复和细胞周期控制的途径调节辐射敏感性
  • 批准号:
    15H04902
  • 财政年份:
    2015
  • 资助金额:
    $ 32.45万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Reguratory mechanisms of radiation sensitivity by molecules expressed in epigenetics-dependent manners
以表观遗传学依赖方式表达的分子的辐射敏感性调节机制
  • 批准号:
    24390289
  • 财政年份:
    2012
  • 资助金额:
    $ 32.45万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Individualized Cancer Therapy Using Cancer Testis Antigens
使用癌症睾丸抗原的个体化癌症治疗
  • 批准号:
    22650233
  • 财政年份:
    2010
  • 资助金额:
    $ 32.45万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Mechanisms of Centrosome Aberrations Induced by DNA damage
DNA损伤引起中心体畸变的机制
  • 批准号:
    21310034
  • 财政年份:
    2009
  • 资助金额:
    $ 32.45万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Mechanisms of the signal transduction machinery in response to spontaneous DNA damage in human cells
信号转导机制响应人体细胞自发 DNA 损伤的机制
  • 批准号:
    18310037
  • 财政年份:
    2006
  • 资助金额:
    $ 32.45万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Prediction of Radiation Sensitivity by Functional Analysis of Reeombinational Repair Genes in Human Cells
通过人体细胞重组修复基因的功能分析预测辐射敏感性
  • 批准号:
    15310039
  • 财政年份:
    2003
  • 资助金额:
    $ 32.45万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Functional analysis of WT1 mutation in acute myeloid leukemia
急性髓系白血病WT1突变的功能分析
  • 批准号:
    10670951
  • 财政年份:
    1998
  • 资助金额:
    $ 32.45万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Functional analysis of the Wilms' tumor suppressor gene WT1 in hematopoiesis.
Wilms 抑癌基因 WT1 在造血中的功能分析。
  • 批准号:
    08671216
  • 财政年份:
    1996
  • 资助金额:
    $ 32.45万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Characterization of receptors for human colony-stimulating factor (GM-CSF and IL-3)
人集落刺激因子(GM-CSF 和 IL-3)受体的表征
  • 批准号:
    01570675
  • 财政年份:
    1989
  • 资助金额:
    $ 32.45万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
In Vitro and In Vivo Function of Platelet-Derived Endothelial Cell Growth Factor
血小板源性内皮细胞生长因子的体外和体内功能
  • 批准号:
    01870033
  • 财政年份:
    1989
  • 资助金额:
    $ 32.45万
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research (B).

相似海外基金

Genome Instability Induced Anti-Tumor Immune Responses
基因组不稳定性诱导的抗肿瘤免疫反应
  • 批准号:
    10626281
  • 财政年份:
    2023
  • 资助金额:
    $ 32.45万
  • 项目类别:
Role of R-loops in transcriptional stress, genome instability, and chronic immune response in Alzheimer's disease
R 环在阿尔茨海默病转录应激、基因组不稳定性和慢性免疫反应中的作用
  • 批准号:
    10807585
  • 财政年份:
    2023
  • 资助金额:
    $ 32.45万
  • 项目类别:
Investigating the connection between aberrant R-loop formation and genome instability
研究异常 R 环形成与基因组不稳定性之间的联系
  • 批准号:
    10750839
  • 财政年份:
    2023
  • 资助金额:
    $ 32.45万
  • 项目类别:
Mechanistic insights into translesion synthesis-dependent genome instability
对跨损伤合成依赖的基因组不稳定性的机制见解
  • 批准号:
    10714421
  • 财政年份:
    2023
  • 资助金额:
    $ 32.45万
  • 项目类别:
CAREER: Mechanisms of G4 DNA Induced Genome Instability
职业:G4 DNA 诱导基因组不稳定的机制
  • 批准号:
    2143016
  • 财政年份:
    2022
  • 资助金额:
    $ 32.45万
  • 项目类别:
    Continuing Grant
Mechanisms Underlying Replication Stress And Genome Instability Upon BRCA2 Deficiency
BRCA2 缺陷引起的复制压力和基因组不稳定的潜在机制
  • 批准号:
    10504242
  • 财政年份:
    2022
  • 资助金额:
    $ 32.45万
  • 项目类别:
Investigating the effect of ionising radiation on cyclic hypoxia-induced replication catastrophe and genome instability in tumours
研究电离辐射对周期性缺氧诱导的肿瘤复制灾难和基因组不稳定性的影响
  • 批准号:
    2745245
  • 财政年份:
    2022
  • 资助金额:
    $ 32.45万
  • 项目类别:
    Studentship
Development of cancer therapy targeting genome instability by centrosome dysregulation and DNA damage
通过中心体失调和 DNA 损伤开发针对基因组不稳定性的癌症疗法
  • 批准号:
    22H02896
  • 财政年份:
    2022
  • 资助金额:
    $ 32.45万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Identification of a novel tumor suppressorof melanoma and UV-induced genome instability
黑色素瘤的新型肿瘤抑制因子和紫外线诱导的基因组不稳定性的鉴定
  • 批准号:
    10539561
  • 财政年份:
    2022
  • 资助金额:
    $ 32.45万
  • 项目类别:
Oncogenic pathway-induced fragile sites: a new paradigm for understanding genome instability in cancer
致癌途径诱导的脆弱位点:了解癌症基因组不稳定性的新范例
  • 批准号:
    10589809
  • 财政年份:
    2022
  • 资助金额:
    $ 32.45万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了